Vimta Labs Limited is testing food and drugs. It also does contract research for clinical research and pre-clinical studies provider in India. It provides analytical, clinical and preclinical services to life sciences industries; quality and safety testing for food and beverage industries; and environment services to a wide spectrum of industries.
Financial Results:
Vimta Labs Ltd reported Revenues for Q1FY24 of ₹82.00 Crores up from ₹79.00 Crore year on year, a rise of 3.8%.
Total Expenses for Q1FY24 of ₹66.00 Crores up from ₹63.00 Crores year on year, a rise of 4.76%.
Consolidated Net Profit of ₹12.00 Crores from ₹12.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.26, down 3.31% from ₹5.44 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.